PROGRESS trial: early TAVI helps patients with moderate aortic stenosis

Medical Tech

Published on:

Source: TCTMDBy: Bailey SalimesDate: 11/02/2026, 12:00:00 AM
SAN DIEGO, CA—Patients with moderate aortic stenosis (AS) and at-risk features do better over 2 years of follow-up when they are treated with TAVI rather than being managed with routine clinical surveillance, the PROGRESS trial shows. The proportion of patients…
Continue reading with a subscription
This article is available to subscribers. Subscribe to read it in full, or sign in if you already have an account.
SubscribeSign in